Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | 15621883869 |
| E-mail: | liutf@jewim.com.cn |
| QQ: | 172688504 |
| Skype: | Chat Now! |
| Address: | West Peitianmen Street,Taian High-Tech Industrial Development Zone, Shandong Province, China, |
|
Jewim Pharmaceutical (Shandong) Co., Ltd. was founded in Dec 1993. It is located at the foot of the world famous Mountain Tai in Shandong Province，China.
It has an aerosol&spray production center that can produce 55 million tubes of medical aerosols in No.49 Chuangye Street, East District, Tai’an Hi-Tech Industrial Development Zone. It has four automatic medical aerosol production lines imported from Switzerland and automatic nasal spray production lines. It is the largest MDIs manufacturer&exporter in China.In June 2013, aerosol & spray passed the GMP certification of Australian TGA.
It also has another factory area of 138,000m2 at Peitianmen Street, South District, Tai’an Hi-Tech Industrial Development Zone, with chemical raw material synthesis workshops, solid preparations (tablets, capsules, granules) workshop,DPIs(capsules&device,the fill machine imported from Germany) workshop,liquid preparations (nebules, sprays,enema etc.) workshop, semi-solid preparations (ointments, creams, gels) workshop.
Formed a strategic partnership with Johnson &johnson, as its well-known trademark “Daktarin" brand of authorized manufacturer, Our cGMP&EHS systems have been getting J &J’s support and recognition.
Our Misson:We are devoted to maintaining the health of all human beings and creating a Jewim brand with products having distinctive characteristics.
Our Core values: Sincere, Devoted, Esptit de Corps，Creative.
Our Quality Policy: To achieve customer satisfaction by consistently meeting regulatory and customer requirements. To provide consistent and sustainable production of safe and effective medicines by consistently improve the QMS.
|
|
| Product Name | MF | CAS | Details |
|---|
| 1-Bromo-2-methoxy-3-nitro-benzene | C7H6BrNO3 | 98775-19-0 | Details |
| 2'-Methoxy-3'-nitro-biphenyl-3-carboxylic acid | C14H11NO5 | 376591-94-5 | Details |
| 3-Carboxyphenylboronic acid | C7H7BO4 | 25487-66-5 | Details |
| 3-Thiophenecarboxylicacid,2-[[(2,6-difluorophenyl)methyl](propoxycarbonyl)amino]-4-[(dimethylamino)methyl]-5-(4-nitrophenyl)-, ethyl ester | C27H29F2N3O6S | 2591260-08-9 | Details |
| 2-Bromo-6-nitrophenol | C6H4BrNO3 | 13073-25-1 | Details |
| Perampanel | C23H15N3O | 380917-97-5 | Details |
| Levosimendan | C14H12N6O | 141505-33-1 | Details |
| Finerenone; BAY 94-8862 | C21H22N4O3 | 1050477-31-0 | Details |
| Umeclidinium Bromide | C29H34BrNO2 | 869113-09-7 | Details |
| endo-8-isopropyl-8-azabicyclo[3.2.1]octan-3-ol | C10H19NO | 3423-25-4 | Details |
| Methyl 5-acetyl-2-benzyloxybenzoate | C17H16O4 | 27475-09-8 | Details |
| (E) -2 - (benzyloxy) - 5 - (2 - (tert butyl imino) acetyl) methyl benzoate | 245322-10-3 | Details |
| Methyl 2- (benzyloxy) - 5- (2- (tert butyl amino) - 1-hydroxyethyl) benzoate | C21H27NO4 | 174607-70-6 | Details |
| 1- (4- (benzyloxy) -3- (hydroxymethyl) phenyl) -2- (tert butyl amino) ethyl-1-alcohol | C20H27NO3 | 56796-66-8 | Details |
| lurasidone impurity C | Details |
| lurasidone impurity D | Details |
| lurasidone impurity E | C28H37ClN4O2S | 139563-29-4 | Details |
| Norpropionyl cyclosonide | C28H38O6 | 161115-59-9 | Details |
| Ciclesonide | C32H45O7 | 141845-82-1 | Details |
| lurasidone impurity L | Details |
| lurasidone impurity N | Details |
| lurasidone impurity O | Details |
| lurasidone impurity G | Details |
| lurasidone impurity H | C28H36N4O3S | 1574569-32-6 | Details |
| lurasidone impurity I | C19H28N4S | 1260138-03-1 | Details |
| lurasidone impurity F | Details |
| lurasidone impurity K | Details |
| lurasidone impurity M | Details |
| lurasidone impurity YHZZⅡ | C28H36N4O3S | 1809325-45-8 | Details |
| 173140-90-4 | C18H15NO3 | 173140-90-4 | Details |
| 3464-71-9 | C16H15ClO2 | 3464-71-9 | Details |
| Tiotropium Bromide impurity A | Details |
| Tiotropium Bromide impurity B | Details |
| Tiotropium Bromide impurity C | Details |
| Tiotropium Bromide impurity D | C18H19NO3S2 | 736108-96-6 | Details |
| Tiotropium Bromide impurity E | C11H10O3S2 | 26447-85-8 | Details |
| Tiotropium Bromide impurity F | Details |
| Tiotropium Bromide impurity G | Details |
| Tiotropium Bromide impurity H | Details |
| Tiotropium Bromide impurity I | C19H22BrNO4S2 | 136521-48-7 | Details |
| Salmeterol | C25H37NO4 | 89365-50-4 | Details |
| Praxole | C10H19Cl2N3S | 104632-25-9 | Details |
| S-2-amino-6-propionamido-4,5,6,7-tetrahydrobenzothiazole | C10H15N3OS | 106006-84-2 | Details |
| 3 - [1 - (3-chloropropyl) - 4-piperidyl] - 6-fluoro-1,2-benzoisoxazole | Details |
| Eponidone | C24H27FN2O4 | 133454-47-4 | Details |
| Zafirlukast | C31H33N3O6S | 107753-78-6 | Details |
| 21-chlorine-9 β, eleven β- Epoxy-17 α- Hydroxy-16 α- Methyl-1,4-pregnanediene-3,20-dione | C22H27ClO4 | 83881-08-7 | Details |
| 3-carboxylicacid,2-[[(2,6-difluorophenyl)methyl](propoxycarbonyl)amino]-4-[(dimethylamino)methyl]-5-(4-nitrophenyl)-, ethyl ester | C25H25F2N3O6S | 2591260-09-0 | Details |
| Carbamic acid, N-[(2,6-difluorophenyl)methyl]-N-[4-[(dimethylamino)methyl]-3-[[(6-methoxy-3-pyridazinyl)amino]carbonyl]-5-(4-nitrophenyl)-2-thienyl]-, propyl ester | C30H30F2N6O6S | 2591260-10-3 | Details |
| 1-(2,6-difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxy-3-pyridazinyl)-6-(4-nitrophenyl)-thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione | C27H22F2N6O5S | 1589503-96-7 | Details |
| Thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione, 6-(4-aminophenyl)-1-[(2,6-difluorophenyl)methyl]-5-[(dimethylamino)methyl]-3-(6-methoxy-3-pyridazinyl | C27H24F2N6O3S | 1589503-93-4 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 | ||||